Endava plc (DAVA)
USD 29.98
(-2.73%)
USD 29.98
(-2.73%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 54.39 Million | 124.51 Million | 120.71 Million | 88.35 Million | 40.24 Million | 35.34 Million |
| Net Income | 17.12 Million | 94.16 Million | 83.09 Million | 43.44 Million | 21.41 Million | 24 Million |
| Depreciation & Amortization | 38.94 Million | 32.92 Million | 28.96 Million | 25.14 Million | 18.72 Million | 7.9 Million |
| Deferred income taxes | 2.07 Million | 20 Million | 19.28 Million | 10.91 Million | 3.84 Million | 6.09 Million |
| Stock-based compensation | 34.67 Million | 31.05 Million | 35 Million | 24.42 Million | 15.66 Million | 12.02 Million |
| Change in working capital | -16.58 Million | -16.07 Million | -21.77 Million | -21.36 Million | -7.75 Million | -11.51 Million |
| Other non-cash items | -2.23 Million | -37.55 Million | -23.86 Million | 5.78 Million | -11.64 Million | -3.15 Million |
| Investing Cash Flow | -290.32 Million | -110.85 Million | -23.87 Million | -107.09 Million | -29.74 Million | -10.05 Million |
| Investments in PPE | -5.48 Million | -13.67 Million | -13.96 Million | -6.11 Million | -9.88 Million | -7.38 Million |
| Acquisitions | -236.11 Million | -79.69 Million | -10.36 Million | -109.99 Million | -23.85 Million | -3.2 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -54.9 Million | -17.48 Million | 456 Thousand | 9.01 Million | 3.98 Million | 533 Thousand |
| Financing Cash Flow | 135.06 Million | -10.99 Million | -5.07 Million | -11.92 Million | 20.87 Million | 26.35 Million |
| Debt repayment | -133.22 Million | -13.48 Million | -13.8 Million | -11.82 Million | -10.85 Million | -23.54 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 8.91 Million | 26 Thousand | 31.01 Million | 44.96 Million |
| Other Financing Activities | 707 Thousand | 2.49 Million | -186 Thousand | -118 Thousand | 727 Thousand | 4.94 Million |
| Accounts receivables | 5.53 Million | -3.93 Million | -37 Million | -19.5 Million | - | -16.34 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -22.11 Million | -12.13 Million | 15.23 Million | -1.85 Million | -7.75 Million | 4.82 Million |
| Cash at beginning of period | 164.7 Million | 162.8 Million | 69.88 Million | 101.32 Million | 70.17 Million | 15.04 Million |
| Cash at end of period | 62.35 Million | 164.7 Million | 162.8 Million | 69.88 Million | 101.32 Million | 70.17 Million |
| Capital Expenditure | -5.48 Million | -13.67 Million | -13.96 Million | -6.11 Million | -9.88 Million | -7.38 Million |
| Effect of forex changes on cash | -1.47 Million | -772 Thousand | 1.15 Million | -781 Thousand | -218 Thousand | 3.47 Million |
| Net cash flow / Change in cash | -102.34 Million | 1.89 Million | 92.92 Million | -31.44 Million | 31.15 Million | 55.12 Million |
| Free Cash Flow | 48.9 Million | 110.84 Million | 106.75 Million | 82.23 Million | 30.36 Million | 27.96 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.85 Million | 17.12 Million | -1.73 Million | 8.34 Million | 12.36 Million | 94.16 Million |
| Depreciation & Amortization | - | 38.94 Million | 8.54 Million | 9.34 Million | 9.41 Million | 32.92 Million |
| Deferred income taxes | -6.34 Million | 2.07 Million | 1.2 Million | 2.25 Million | 4.94 Million | 20 Million |
| Stock-based compensation | - | 34.67 Million | 6.18 Million | 13.61 Million | 9.93 Million | 31.05 Million |
| Change in working capital | -7.76 Million | -16.58 Million | -5.49 Million | 10.86 Million | -14.17 Million | -16.07 Million |
| Other non-cash items | -45.99 Million | -2.23 Million | 11.92 Million | -9.39 Million | -5.9 Million | -37.55 Million |
| Investing Cash Flow | -266.36 Million | -290.32 Million | -11.86 Million | -1.99 Million | -10.1 Million | -110.85 Million |
| Investments in PPE | -1.79 Million | -5.48 Million | -1.49 Million | -1.39 Million | -807 Thousand | -13.67 Million |
| Acquisitions | -216.88 Million | -236.11 Million | -12.51 Million | -2.52 Million | -4.18 Million | -79.69 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -48.25 Million | -54.9 Million | 63 Thousand | 1.92 Million | -5.11 Million | -17.48 Million |
| Financing Cash Flow | 139.92 Million | 135.06 Million | -310 Thousand | -624 Thousand | -3.93 Million | -10.99 Million |
| Debt repayment | -143.88 Million | -133.22 Million | -3.33 Million | -3.5 Million | -3.92 Million | -13.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -115 Thousand | 707 Thousand | 592 Thousand | 2.87 Million | -13 Thousand | 2.49 Million |
| Accounts receivables | - | - | - | 7.87 Million | - | -3.93 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.76 Million | - | -5.49 Million | 2.99 Million | -14.17 Million | -12.13 Million |
| Cash at beginning of period | 190.02 Million | 164.7 Million | 198.6 Million | 168.19 Million | 164.7 Million | 162.8 Million |
| Cash at end of period | 62.35 Million | 62.35 Million | 190.02 Million | 198.6 Million | 168.19 Million | 164.7 Million |
| Capital Expenditure | -1.79 Million | -5.48 Million | -1.49 Million | -1.39 Million | -807 Thousand | -13.67 Million |
| Effect of forex changes on cash | -991 Thousand | -1.47 Million | 590 Thousand | -2 Million | 935 Thousand | -772 Thousand |
| Net cash flow / Change in cash | -127.66 Million | -102.34 Million | -8.58 Million | 30.41 Million | 3.48 Million | 1.89 Million |
| Free Cash Flow | -2.02 Million | 48.9 Million | 1.51 Million | 33.64 Million | 15.78 Million | 110.84 Million |
322000
ASAP
EPBIO
688618
DG
301004